Anti-human STK4 antibody in study to determine the most suitable therapy for the STK4-deficiency-related disease

June, 2021 (Department of Pediatric Immunology, Hacettepe University Medical School, Ankara, Turkey)

Serine-threonine kinase-4 (STK4) deficiency is an autosomal recessive combined immunodeficiency (CID).

Using our anti-human STK4 antibody and Westernblotting, this newly published study aimed to define clinical and laboratory features to improve the differential diagnosis and determine the most suitable therapy for the STK4-deficiency-related disease.


Image from Atlas Antibodies product page: Western blot analysis in Caco-2 cells transfected with control siRNA, target specific siRNA probe #1, using Anti-STK4 antibody. Remaining relative intensity is presented.


Article page:

All about our Anti-STK4 antibodies read here: